Delayed tacrolimus is safe with basiliximab induction therapy.
Lee
Kang H
KH
Da Costa
Maureen
M
Lim
Seng-Gee
SG
Tan
Kai-Chah
KC
D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D000077552:Basiliximab; D002102:Cadaver; D004334:Drug Administration Schedule; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000379:methods*; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D011184:Postoperative Period; D011993:Recombinant Fusion Proteins; D012449:Safety; D016559:Tacrolimus / Q000008:administration & dosage / Q000627:therapeutic use*; D014019:Tissue Donors
D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D011993:Recombinant Fusion Proteins; D000077552:Basiliximab; D016559:Tacrolimus; D008775:Methylprednisolone